Related Experiment Video
Updated: Jul 14, 2026
06:45
A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay
Published on: July 26, 2017
Computer simulation of normal and pathological copper metabolism in man
1University of Nevada Reno 89503-2722.
Computers in Biology and Medicine
|January 1, 1993
Summary
Computer simulations accurately model human copper metabolism, including Wilson's disease (hepatolenticular degeneration) and Menkes' disease (steely-hair syndrome). The models suggest specific genetic defects underlying these copper metabolism disorders.
Area of Science:
- Biochemistry
- Computational Biology
- Medical Genetics
Background:
- Copper is an essential trace element vital for numerous physiological processes.
- Disruptions in copper metabolism can lead to severe genetic disorders like Wilson's disease and Menkes' disease.
Purpose of the Study:
- To develop and validate a digital computer simulation of human copper metabolism.
- To utilize the simulation to investigate the underlying mechanisms of Wilson's disease and Menkes' disease.
Main Methods:
- A digital computer simulation model was created to represent human copper metabolism.
- The simulation's accuracy was validated against existing normal human copper metabolism data.
- Specific genetic defect scenarios were simulated to model Wilson's disease and Menkes' disease.
Main Results:
- The computer simulation demonstrated a high degree of agreement with established normal human copper metabolism data.
- Simulation of unavailable accumulated liver copper successfully modeled Wilson's disease, suggesting a mechanism of induced urinary excretion.
- Simulation of impaired gastrointestinal copper absorption accurately modeled Menkes' disease.
Conclusions:
- The developed computer simulation is a reliable tool for studying human copper metabolism.
- The simulation provides insights into the potential genetic defects causing Wilson's disease and Menkes' disease.
- The findings support distinct molecular mechanisms for Wilson's disease and Menkes' disease based on copper handling defects.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...